Industries Market Research Reports

Subscribe to RSS Feed
  1. 05 Apr 2023  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Pharmaceutical Industry Outlook, 2023

    Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

    Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japa...

    $4,950.00

    Special Price $4,207.50 save 15 %

  2. 19 Dec 2022  |  North America  |  Market Outlook

    Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

    An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

    $2,450.00

    Special Price $2,082.50 save 15 %

  3. 08 Mar 2022  |  North America  |  Market Outlook

    Global Pharmaceuticals Outlook, 2022

    The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

    Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

    $4,950.00

    Special Price $3,712.50 save 25 %

  4. 09 Apr 2018  |  North America  |  Market Outlook

    Global Life Sciences Industry Outlook, 2018

    Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

    The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

    $4,950.00

    Special Price $3,712.50 save 25 %